Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin.

Objective: To examine the mechanisms responsible for improved glycemia with combined sodium-glucose cotransporter 2 inhibitor (SGLT2i) plus dipeptidyl peptidase 4 inhibitor therapy in type 2 diabetes.Research Design and Methods: Fifty-six patients (HbA1c 8.9 ± 0.2% [74 ± 2 mmol/mol]) were randomized...

Full description

Bibliographic Details

Published in:	Diabetes Care Vol. 43; no. 10; pp. 2519 - 2528
Main Authors:	Qin, Yuejuan, Adams, John, Solis-Herrera, Carolina, Triplitt, Curtis, DeFronzo, Ralph, Cersosimo, Eugenio
Format:	research Journal Article
Published:	American Diabetes Association Oct2020
Online Access:	View this record in EBSCOhost